These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3501959)

  • 1. Identification of T-cell-reactive antigens that protect BALB/c mice against Leishmania major.
    Scott P; Pearce E; Heath S; Sher A
    Ann Inst Pasteur Immunol; 1987; 138(5):771-4. PubMed ID: 3501959
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD; Locksley RM; Tubbs C; Raff HV
    J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to leishmaniasis: what properties delineate a protective antigen?
    Russell DG
    Ann Inst Pasteur Immunol; 1987; 138(5):774-81. PubMed ID: 3501960
    [No Abstract]   [Full Text] [Related]  

  • 5. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H; Scollay R
    Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subsets of specific T cells and experimental cutaneous leishmaniasis.
    Louis JA; Pedrazzini T; Titus RG; Muller I; Farrell JP; Kindler V; Vassalli P; Marchal G; Milon G
    Ann Inst Pasteur Immunol; 1987; 138(5):755-8. PubMed ID: 3501956
    [No Abstract]   [Full Text] [Related]  

  • 7. Leishmania major: analysis of lymphocyte and macrophage cellular phenotypes during infection of susceptible and resistant mice.
    Heinzel FP; Sadick MD; Locksley RM
    Exp Parasitol; 1988 Apr; 65(2):258-68. PubMed ID: 3127233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of class II antigens in different routes of alloactivation.
    Sutherland R; Heath W; Boyle W
    Transplant Proc; 1986 Apr; 18(2):298-301. PubMed ID: 2938317
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of T cells in the unusual cutaneous responses to Leishmania in BALB/c mice.
    Liew FY; Howard JG
    Curr Top Microbiol Immunol; 1985; 122():122-7. PubMed ID: 3876194
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice.
    Titus RG; Ceredig R; Cerottini JC; Louis JA
    J Immunol; 1985 Sep; 135(3):2108-14. PubMed ID: 3926895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous leishmaniasis. The defect in T cell influx in BALB/c mice.
    McElrath MJ; Kaplan G; Nusrat A; Cohn ZA
    J Exp Med; 1987 Feb; 165(2):546-59. PubMed ID: 3546576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell responses and immunity to experimental infection with leishmania major.
    Müller I; Pedrazzini T; Farrell JP; Louis J
    Annu Rev Immunol; 1989; 7():561-78. PubMed ID: 2653376
    [No Abstract]   [Full Text] [Related]  

  • 13. A recombinant fusion protein displaying murine and human MHC class I- and II-specific epitopes protects against Leishmania amazonensis infection.
    Martins VT; Lage DP; Duarte MC; Carvalho AM; Costa LE; Mendes TA; Vale DL; Menezes-Souza D; Roatt BM; Tavares CA; Soto M; Coelho EA
    Cell Immunol; 2017 Mar; 313():32-42. PubMed ID: 28049560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ T cell response to Mls-1a determinants involves major histocompatibility complex class II molecules.
    Chvatchko Y; MacDonald HR
    J Exp Med; 1991 Mar; 173(3):779-82. PubMed ID: 1825506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes.
    Scott P; Caspar P; Sher A
    J Immunol; 1990 Feb; 144(3):1075-9. PubMed ID: 2295814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation from an alloreactive T-cell line of a clone which cross-reacts with a self H2-E-restricted minor alloantigen.
    Owens T; Liddell ME; Crispe IN
    Cell Immunol; 1984 May; 85(2):436-46. PubMed ID: 6609002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD4 can confer major histocompatibility complex class II-associated superantigen reactivity upon a T cell receptor derived from a CD8-dependent cytotoxic T lymphocyte clone.
    Wallace VA; Ohashi PS; Hengartner H; Mak TW
    Eur J Immunol; 1990 Nov; 20(11):2471-7. PubMed ID: 2123792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of protozoan parasites by murine T lymphocytes. II. Role of the H-2 gene complex in interactions between antigen-presenting macrophages and Leishmania-immune T lymphocytes.
    Louis JA; Moedder E; MacDonald HR; Engers HD
    J Immunol; 1981 May; 126(5):1661-6. PubMed ID: 6452473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of Mlsa-reactivity among Ab-restricted, H-Y-specific T cell clones.
    Frangoulis B; Klein J
    J Immunogenet; 1988; 15(1-3):101-9. PubMed ID: 3148656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.